173 related items for PubMed ID: 26667396
1. Treatment of chronic kidney disease using a traditional Chinese medicine, Flos Abelmoschus manihot (Linnaeus) Medicus (Malvaceae).
Chen Y, Cai G, Sun X, Chen X.
Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):145-8. PubMed ID: 26667396
[Abstract] [Full Text] [Related]
2. Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial.
Zhang L, Li P, Xing CY, Zhao JY, He YN, Wang JQ, Wu XF, Liu ZS, Zhang AP, Lin HL, Ding XQ, Yin AP, Yuan FH, Fu P, Hao L, Miao LN, Xie RJ, Wang R, Zhou CH, Guan GJ, Hu Z, Lin S, Chang M, Zhang M, He LQ, Mei CL, Wang L, Chen X.
Am J Kidney Dis; 2014 Jul; 64(1):57-65. PubMed ID: 24631042
[Abstract] [Full Text] [Related]
3. Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases.
Li N, Tang H, Wu L, Ge H, Wang Y, Yu H, Zhang X, Ma J, Gu HF.
Phytother Res; 2021 Jan; 35(1):198-206. PubMed ID: 32716080
[Abstract] [Full Text] [Related]
4. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
Li P, Chen YZ, Lin HL, Ni ZH, Zhan YL, Wang R, Yang HT, Fang JA, Wang NS, Li WG, Sun XF, Chen XM.
Trials; 2017 Apr 11; 18(1):170. PubMed ID: 28395659
[Abstract] [Full Text] [Related]
5. Efficacy and safety of Flos Abelmoschus manihot (Malvaceae) on type 2 diabetic nephropathy: A systematic review.
Chen YZ, Gong ZX, Cai GY, Gao Q, Chen XM, Tang L, Wei RB, Zhou JH.
Chin J Integr Med; 2015 Jun 11; 21(6):464-72. PubMed ID: 25491537
[Abstract] [Full Text] [Related]
6. Metabolic profiles of the Flos Abelmoschus manihot extract by intestinal bacteria from the normal and CKD model rats based on UPLC-Q-TOF/MS.
Du LY, Tao JH, Jiang S, Qian DW, Guo JM, Duan JA.
Biomed Chromatogr; 2017 Feb 11; 31(2):. PubMed ID: 27451133
[Abstract] [Full Text] [Related]
7. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, ameliorates adriamycin-induced renal inflammation and glomerular injury via inhibiting p38MAPK signaling pathway activity in rats.
Tu Y, Sun W, Wan YG, Che XY, Pu HP, Yin XJ, Chen HL, Meng XJ, Huang YR, Shi XM.
J Ethnopharmacol; 2013 May 20; 147(2):311-20. PubMed ID: 23518420
[Abstract] [Full Text] [Related]
8. Conjugated metabolites represent the major circulating forms of Abelmoschus manihot in vivo and show an altered pharmacokinetic profile in renal pathology.
Guo J, Du L, Shang E, Li T, Liu Y, Qian D, Tang Y, Duan J.
Pharm Biol; 2016 May 20; 54(4):595-603. PubMed ID: 26186460
[Abstract] [Full Text] [Related]
9. Renal protective effect and action mechanism of Huangkui capsule and its main five flavonoids.
Cai HD, Su SL, Qian DW, Guo S, Tao WW, Cong XD, Tang R, Duan JA.
J Ethnopharmacol; 2017 Jul 12; 206():152-159. PubMed ID: 28408246
[Abstract] [Full Text] [Related]
10. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM, Shen SM, Wan YG, Sun W, Chen HL, Huang MM, Yang JJ, Wu W, Tang HT, Tang RM.
J Ethnopharmacol; 2015 Sep 15; 173():256-65. PubMed ID: 26226437
[Abstract] [Full Text] [Related]
11. [Mechanisms and effects of Abelmoschus manihot preparations in treating chronic kidney disease].
Chen P, Wan Y, Wang C, Zhao Q, Wei Q, Tu Y, Yin X.
Zhongguo Zhong Yao Za Zhi; 2012 Aug 15; 37(15):2252-6. PubMed ID: 23189729
[Abstract] [Full Text] [Related]
12. Identification and characterization of a cytotoxic polysaccharide from the flower of Abelmoschus manihot.
Zheng X, Liu Z, Li S, Wang L, Lv J, Li J, Ma X, Fan L, Qian F.
Int J Biol Macromol; 2016 Jan 15; 82():284-90. PubMed ID: 26478094
[Abstract] [Full Text] [Related]
13. Hepatoprotective evaluation of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic: In vitro and in vivo studies.
Ai G, Liu Q, Hua W, Huang Z, Wang D.
J Ethnopharmacol; 2013 Apr 19; 146(3):794-802. PubMed ID: 23422335
[Abstract] [Full Text] [Related]
14. Investigation of in vivo metabolic profile of Abelmoschus Manihot based on pattern recognition analysis.
Guo JM, Lin P, Lu YW, Duan JA, Shang EX, Qian DW, Tang YP.
J Ethnopharmacol; 2013 Jun 21; 148(1):297-304. PubMed ID: 23632309
[Abstract] [Full Text] [Related]
15. Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats.
Yan JY, Ai G, Zhang XJ, Xu HJ, Huang ZM.
J Ethnopharmacol; 2015 Aug 22; 172():202-13. PubMed ID: 26133062
[Abstract] [Full Text] [Related]
16. Dynamic changes of flavonoids in Abelmoschus manihot different organs at different growth periods by UPLC-MS/MS.
Pan X, Du L, Tao J, Jiang S, Qian D, Duan J.
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug 01; 1059():21-26. PubMed ID: 28558340
[Abstract] [Full Text] [Related]
17. Glomerular disease. Antiproteinuric efficacy of A. manihot superior to losartan.
Carney EF.
Nat Rev Nephrol; 2014 Jun 01; 10(6):300. PubMed ID: 24709846
[No Abstract] [Full Text] [Related]
18. [Effects of huangkui capsule on renal inflammatory injury by intervening p38MAPK signaling pathway in rats with adriamycin-induced nephropathy].
Zhao Q, Wan YG, Sun W, Wang CJ, Wei QX, Chen HL, Meng XJ.
Zhongguo Zhong Yao Za Zhi; 2012 Oct 01; 37(19):2926-34. PubMed ID: 23270236
[Abstract] [Full Text] [Related]
19. The pharmacological mechanism of Abelmoschus manihot in the treatment of chronic kidney disease.
Wei C, Wang C, Li R, Bai Y, Wang X, Fang Q, Chen X, Li P.
Heliyon; 2023 Nov 01; 9(11):e22017. PubMed ID: 38058638
[Abstract] [Full Text] [Related]
20. A single-cell profile reveals the transcriptional regulation responded for Abelmoschus manihot (L.) treatment in diabetic kidney disease.
Wu C, Tang H, Cui X, Li N, Fei J, Ge H, Wu L, Wu J, Gu HF.
Phytomedicine; 2024 Jul 25; 130():155642. PubMed ID: 38759315
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
